recombinant coagulation factor VIIa (Chengdu Rongsheng Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant coagulation factor VIIa (Chengdu Rongsheng Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFactor VIIa agonists
TargetsCoagulation factor VII
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A